Literature DB >> 20203100

Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma.

Lihua Jin1, Dariusz Martynowski, Songyang Zheng, Taira Wada, Wen Xie, Yong Li.   

Abstract

The retinoic acid-related orphan receptor gamma (RORgamma) has important roles in development and metabolic homeostasis. Although the biological functions of RORgamma have been studied extensively, no ligands for RORgamma have been identified, and no structure of RORgamma has been reported. In this study, we showed that hydroxycholesterols promote the recruitment of coactivators by RORgamma using biochemical assays. We also report the crystal structures of the RORgamma ligand-binding domain bound with hydroxycholesterols. The structures reveal the binding modes of various hydroxycholesterols in the RORgamma pocket, with the receptors all adopting the canonical active conformation. Mutations that disrupt the binding of hydroxycholesterols abolish the constitutive activity of RORgamma. Our observations suggest an important role for the endogenous hydroxycholesterols in modulating RORgamma-dependent biological processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203100      PMCID: PMC2870936          DOI: 10.1210/me.2009-0507

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  24 in total

1.  Requirement for RORgamma in thymocyte survival and lymphoid organ development.

Authors:  Z Sun; D Unutmaz; Y R Zou; M J Sunshine; A Pierani; S Brenner-Morton; R E Mebius; D R Littman
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

Review 2.  Orphan nuclear receptors: shifting endocrinology into reverse.

Authors:  S A Kliewer; J M Lehmann; T M Willson
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

3.  X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha.

Authors:  Joerg A Kallen; Jean-Marc Schlaeppi; Francis Bitsch; Sabine Geisse; Martin Geiser; Isabelle Delhon; Brigitte Fournier
Journal:  Structure       Date:  2002-12       Impact factor: 5.006

4.  Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1.

Authors:  Yong Li; Mihwa Choi; Greg Cavey; Jennifer Daugherty; Kelly Suino; Amanda Kovach; Nathan C Bingham; Steven A Kliewer; H Eric Xu
Journal:  Mol Cell       Date:  2005-02-18       Impact factor: 17.970

Review 5.  Nuclear receptors and lipid physiology: opening the X-files.

Authors:  A Chawla; J J Repa; R M Evans; D J Mangelsdorf
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

6.  Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice.

Authors:  Wenling Chen; Guoxen Chen; Daphne L Head; David J Mangelsdorf; David W Russell
Journal:  Cell Metab       Date:  2007-01       Impact factor: 27.287

7.  Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.

Authors:  Yong Li; Kelly Suino; Jennifer Daugherty; H Eric Xu
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

Review 8.  The emerging role of nuclear receptor RORalpha and its crosstalk with LXR in xeno- and endobiotic gene regulation.

Authors:  Taira Wada; Hong Soon Kang; Anton M Jetten; Wen Xie
Journal:  Exp Biol Med (Maywood)       Date:  2008-06-05

9.  Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans.

Authors:  Daniel L Motola; Carolyn L Cummins; Veerle Rottiers; Kamalesh K Sharma; Tingting Li; Yong Li; Kelly Suino-Powell; H Eric Xu; Richard J Auchus; Adam Antebi; David J Mangelsdorf
Journal:  Cell       Date:  2006-03-09       Impact factor: 41.582

10.  All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta.

Authors:  Catherine Stehlin-Gaon; Dominica Willmann; Denis Zeyer; Sarah Sanglier; Alain Van Dorsselaer; Jean-Paul Renaud; Dino Moras; Roland Schüle
Journal:  Nat Struct Biol       Date:  2003-09-07
View more
  80 in total

1.  Identification of SR2211: a potent synthetic RORγ-selective modulator.

Authors:  Naresh Kumar; Brent Lyda; Mi Ra Chang; Janelle L Lauer; Laura A Solt; Thomas P Burris; Theodore M Kamenecka; Patrick R Griffin
Journal:  ACS Chem Biol       Date:  2012-02-13       Impact factor: 5.100

Review 2.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

3.  Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.

Authors:  Yongjun Wang; Naresh Kumar; Philippe Nuhant; Michael D Cameron; Monica A Istrate; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-11-19       Impact factor: 5.100

Review 4.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

5.  Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist.

Authors:  Naresh Kumar; Douglas J Kojetin; Laura A Solt; K Ganesh Kumar; Philippe Nuhant; Derek R Duckett; Michael D Cameron; Andrew A Butler; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-12-06       Impact factor: 5.100

6.  Time window expansion for HDX analysis of an intrinsically disordered protein.

Authors:  Devrishi Goswami; Srikripa Devarakonda; Michael J Chalmers; Bruce D Pascal; Bruce M Spiegelman; Patrick R Griffin
Journal:  J Am Soc Mass Spectrom       Date:  2013-07-25       Impact factor: 3.109

Review 7.  The orphan nuclear receptors at their 25-year reunion.

Authors:  Shannon E Mullican; Joanna R Dispirito; Mitchell A Lazar
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

8.  Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors.

Authors:  Jun R Huh; Erika E Englund; Hang Wang; Ruili Huang; Pengxiang Huang; Fraydoon Rastinejad; James Inglese; Christopher P Austin; Ronald L Johnson; Wenwei Huang; Dan R Littman
Journal:  ACS Med Chem Lett       Date:  2013-01-10       Impact factor: 4.345

9.  Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation.

Authors:  Pejman Soroosh; Jiejun Wu; Xiaohua Xue; Jiao Song; Steven W Sutton; Marciano Sablad; Jingxue Yu; Marina I Nelen; Xuejun Liu; Glenda Castro; Rosa Luna; Shelby Crawford; Homayon Banie; Rose A Dandridge; Xiaohu Deng; Anton Bittner; Chester Kuei; Mandana Tootoonchi; Natasha Rozenkrants; Krystal Herman; Jingjin Gao; Xia V Yang; Kacey Sachen; Karen Ngo; Wai-Ping Fung-Leung; Steven Nguyen; Aimee de Leon-Tabaldo; Jonathan Blevitt; Yan Zhang; Maxwell D Cummings; Tadimeti Rao; Neelakandha S Mani; Changlu Liu; Murray McKinnon; Marcos E Milla; Anne M Fourie; Siquan Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

Review 10.  REV-ERB and ROR nuclear receptors as drug targets.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.